Bulgaria is set to adopt the euro on 1 January 2026, marking a major shift in its monetary regime and one that carries important implications for pharmaceutical pricing and market dynamics. Although the domestic legislative transition appears relatively straightforward — with automatic conversion rules for local...
PharmDedict proudly represents Bulgaria & Romania in the EuDRAcon family - the European Drug Regulatory Affairs Consultants Network. EuDRAcon covers 30+ countries, including all EU member states, Norway, Switzerland, and Liechtenstein. Every member is selected based on proven regulatory expertise, reliability, and responsiveness. Founded in 2007,...
Vagabond Magazine*: The General Manager of PharmDedict knows the ins and outs of drug regulations Drugs in the pharmacies have gone a long way before reaching us and improving our health. To a significant extent, this is thanks to the work of companies such as PharmDedict....
The prices of RX medicinal products are regulated by the National Council on Pricing and Reimbursement in Bulgaria. Before placing any RX medicinal product (whether reimbursed or non-reimbursed) on the Bulgarian market the concerned marketing authorisation holders (MAH) have to initiate administrative procedure for price...